Pharma BD Deal Intelligence
Allergan will pay $350 million upfront plus $25 million contingent on net sales targets; Allergan plans to operate SkinMedica as a separate global business…
Allergan completed its acquisition of SkinMedica for approximately $350 million roughly one month after the November 16, 2012 announcement; SkinMedica will…
Practical Dermatology noted Allergan would operate SkinMedica as a separate global business out of Carlsbad, CA — preserving brand identity in the…
Source summaries from our enrichment pipeline; follow links for originals.
All 6 sources with sentiment breakdown →
Allergan acquired SkinMedica for $350M upfront plus up to $25M sales-based contingent. Complemented existing Botox/Juvederm aesthetics franchise with leadership in physician-dispensed topical aesthetics skincare. Excluded Colorescience makeup line.
Assessment window: 5yr post-close.
| Deal | Year | Value | Outcome |
|---|---|---|---|
| Allergan plc / SkinMedica, Inc. (this deal) | 2012 | $375M | 55 |
| Allergan plc / Merck & Co., Inc. (CGRP receptor antagonist program) | 2015 | $250M | 91 |
| Allergan plc / Inamed Corporation | 2005 | $3.2B | 50 |
| Allergan plc / Oculeve, Inc. | 2015 | $250M | 33 |
| Allergan plc / Zeltiq Aesthetics, Inc. | 2017 | $2.5B | 32 |
| Allergan plc / Kythera Biopharmaceuticals, Inc. | 2015 | $2.1B | 23 |
| Allergan plc / Anterios, Inc. | 2016 | $90M | 19 |
← Browse all deals · How we score deals
More: 2012 deals · Allergan plc deals · Dermatology deals